Cargando…
In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach
Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CC...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045570/ https://www.ncbi.nlm.nih.gov/pubmed/27713840 http://dx.doi.org/10.1016/j.jare.2016.09.004 |
_version_ | 1782457142073098240 |
---|---|
author | Gandhi, Tamanna Melge, Anu R. Gopi Mohan, C. |
author_facet | Gandhi, Tamanna Melge, Anu R. Gopi Mohan, C. |
author_sort | Gandhi, Tamanna |
collection | PubMed |
description | Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CCBs). Using HipHop module in the CATALYST 4.10 software, both selective and non-selective HipHop pharmacophore maps for T-type CCBs were developed to identify its important common pharmacophoric features. HipHop pharmacophore map of the selective T-type CCBs contained six different chemical features, namely ring aromatic (R), positive ionizable (P), two hydrophobic aromatic (Y), hydrophobic aliphatic (Z), hydrogen bond acceptor (H) and hydrogen bond donor (D). However, non-selective T-type CCBs contain all the above mentioned features except ring aromatic (R). The present ligand-based pharmacophore mapping approach could thus be utilized in classifying selective vs. non-selective T-type CCBs. Further, the model can be used for virtual screening of several small molecule databases. |
format | Online Article Text |
id | pubmed-5045570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-50455702016-10-06 In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach Gandhi, Tamanna Melge, Anu R. Gopi Mohan, C. J Adv Res Original Article Limited progress has been made in the quest to identify both selective and non-toxic T-type calcium channel blocking compounds. The present research work was directed toward slaking the same by identifying the selective three dimensional (3D) pharmacophore map for T-type calcium channel blockers (CCBs). Using HipHop module in the CATALYST 4.10 software, both selective and non-selective HipHop pharmacophore maps for T-type CCBs were developed to identify its important common pharmacophoric features. HipHop pharmacophore map of the selective T-type CCBs contained six different chemical features, namely ring aromatic (R), positive ionizable (P), two hydrophobic aromatic (Y), hydrophobic aliphatic (Z), hydrogen bond acceptor (H) and hydrogen bond donor (D). However, non-selective T-type CCBs contain all the above mentioned features except ring aromatic (R). The present ligand-based pharmacophore mapping approach could thus be utilized in classifying selective vs. non-selective T-type CCBs. Further, the model can be used for virtual screening of several small molecule databases. Elsevier 2016-11 2016-09-16 /pmc/articles/PMC5045570/ /pubmed/27713840 http://dx.doi.org/10.1016/j.jare.2016.09.004 Text en © 2016 Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Gandhi, Tamanna Melge, Anu R. Gopi Mohan, C. In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title | In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title_full | In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title_fullStr | In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title_full_unstemmed | In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title_short | In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach |
title_sort | in silico identification of t-type calcium channel blockers: a ligand-based pharmacophore mapping approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045570/ https://www.ncbi.nlm.nih.gov/pubmed/27713840 http://dx.doi.org/10.1016/j.jare.2016.09.004 |
work_keys_str_mv | AT gandhitamanna insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach AT melgeanur insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach AT gopimohanc insilicoidentificationofttypecalciumchannelblockersaligandbasedpharmacophoremappingapproach |